JLHL
Jupiter Life Line Hospitals Ltd.
Each stock's 10,000-path forecast, rendered as light.
Jupiter Life Line Hospitals Ltd. (JLHL) Stock Analysis & Case Study
Is JLHL a good buy? The data-driven verdict.
Jupiter Life Line Hospitals Ltd. (JLHL) trades at ₹320,on the numbers it mixed signals, a Downstox Snapshot Score of 49/100.
On the numbers, Jupiter Life Line Hospitals Ltd. (JLHL) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 54.9× earnings, ROE of 13.1%, a 62% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
JLHL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How JLHL ranks against the 2,373 companies in our screener
- JLHL's market cap of 10,497 Cr ranks in the 76th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- JLHL's book value of ₹47 ranks in the 32nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- JLHL's promoter holding of 40.9% ranks in the 17th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- JLHL's 3-year profit (PAT) growth of 37.0% ranks in the 76th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- JLHL's 3-year revenue growth of 19.0% ranks in the 72nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- JLHL's debt-to-equity ratio of 0.38x is lower than 44% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is JLHL overvalued? JLHL P/E vs peers
JLHL trades at 54.9× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
JLHL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.8y of JLHL history (14%/yr drift, 25%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| JLHL 2027 | ₹251 | ₹347 | ₹481 | +8% |
| JLHL 2028 | ₹236 | ₹376 | ₹600 | +18% |
| JLHL 2029 | ₹231 | ₹408 | ₹720 | +27% |
| JLHL 2030 | ₹230 | ₹443 | ₹851 | +38% |
| JLHL 2031 | ₹232 | ₹480 | ₹991 | +50% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability JLHL goes up, or doubles?
The bull case for JLHL
- JLHL's return on equity of 13.1% ranks in the 64th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A 10,000-path probability model puts a 62% chance the price is higher in a year, with a median target of ₹347 (+8%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹720.
The bear case & risks
- JLHL's P/E of 54.9x is lower than 24% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹231.
JLHL volatility & expected range, how bumpy is the ride?
Over the last 2.8 years JLHL compounded at 14%/year with annualized volatility of 25%. That volatility implies a 1-year 80% range of ₹251-₹481, the honest backbone behind any single price target.
JLHL price forecast, the full 60-month probability fan
JLHL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds JLHL hits common targets within the simulated horizon?
Full multi-horizon detail on the JLHL price target & forecast page.
JLHL Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. JLHL scores 6/8, mixed financial health.
JLHL MTF margin & leverage across 9 brokers
Margin Trading Facility lets you buy JLHL with part of the capital. Lower margin % = higher leverage. Rates compared across 9 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| ZerodhaCHEAPEST | 27.15% | 3.7× |
| Groww | 27.21% | 3.7× |
| Dhan | 27.15% | 3.7× |
| Kotak Neo | 100.00% | 1.0× |
| Pocketful | 27.21% | 3.7× |
| Fyers | 27.78% | 3.6× |
| Anand RathiCHEAPEST | 27.15% | 3.7× |
| Share India | 27.21% | 3.7× |
Compare every broker on the JLHL MTF page.
About Jupiter Life Line Hospitals Ltd.: sector, index & market-cap context
Jupiter Life Line Hospitals Ltd. (JLHL) is a small-cap NSE-listed company, with a market capitalisation of ₹10,497 Cr. See more stocks on our screener.
How the JLHL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Jupiter Life Line Hospitals Ltd.'s public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
JLHL analysis, FAQs
Is Jupiter Life Line Hospitals Ltd. (JLHL) a good buy?
On the numbers, Jupiter Life Line Hospitals Ltd. (JLHL) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 54.9× earnings, ROE of 13.1%, a 62% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is JLHL overvalued or undervalued?
JLHL trades at 54.9× earnings, expensive versus the ~22× long-run Nifty average.
What is the JLHL share price target for 2031?
JLHL's probability-weighted 2031 median target is ₹480, with an 80% range of ₹232-₹991 (10,000-path Monte-Carlo).
What is the probability JLHL doubles in 5 years?
The modelled probability of JLHL reaching ₹640 (2×) within 5 years is 31%.
What is the bull case for JLHL?
JLHL's return on equity of 13.1% ranks in the 64th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A 10,000-path probability model puts a 62% chance the price is higher in a year, with a median target of ₹347 (+8%).
What are the risks in JLHL?
JLHL's P/E of 54.9x is lower than 24% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.